IFP Advisors »

Adaptimmune Therapeutics shares owned by IFP Advisors

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by IFP Advisors from 13F filings

Historical chart of IFP Advisors investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by IFP Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by IFP Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.6k 3.0k 0.54
2024-09-30 $2.9k 3.0k 0.95
2024-06-30 $2.9k 3.0k 0.97